multidisciplinary team Side-icon

Artemide Lung 02 (NCT06692738)

Brief Summary

A Phase II clinical trial designed to investigate the effectiveness and safety of [intervention/drug name] in patients with advanced-stage lung cancer. The study focuses on progression-free survival and overall response rate.

Official Title

A Phase II Study Evaluating the Effectiveness of [Full Study Title Placeholder] in Patients with Advanced Lung Cancer.

Conditions

Advanced Non-Small Cell Lung Cancer (NSCLC)

Artemide Lung 03 (NCT06627647)

Brief Summary

This is a Phase I/II trial to evaluate the safety, tolerability, and early efficacy of [specific intervention] in patients with early-stage lung cancer. The study aims to determine the recommended dosage for further trials.

Official Title

A Phase I/II Trial Investigating [Full Study Title Placeholder] for Patients with Early-Stage Lung Cancer.

Conditions

Early-Stage Lung Cancer

multidisciplinary teamSide-icon